Advisory Services Network’s BioVie BIVI Stock Holding History

Advisory Services Network’s Portfolio BIVI Stock Details BIVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-41	Closed	-$5.12K	–	1704
2023 Q4	$5.12K	Buy	+41	New	+$12.3K	﹤0.01%	3105
2023 Q2	–	Sell	-4	Closed	-$2.86K	–	1687
2023 Q1	$2.86K	Sell	4 -9	-69%	-$5.96K	﹤0.01%	3335
2022 Q4	$10.3K	Buy	+13	New	+$7.03K	﹤0.01%	2845
2021 Q3	–	Sell	-3	Closed	-$6K	–	1595
2021 Q2	$6K	Buy	+3	New	+$4.67K	﹤0.01%	2990

Other funds holding BIVI

ACM

Altium Capital Management New York $42M AUM

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

Advisory Services Network's BIVI Position: Q1 2024 in Review

Advisory Services Network sold out of BioVie (BIVI) in Q1 2024, closing a stake of 41 shares — an estimated $5.12K sold.

Advisory Services Network first reported a position in BIVI in Q2 2021 and held it in 4 quarters. The position peaked at $10.3K in Q4 2022. 49 funds tracked by Wall St. Rank hold BIVI as of Q1 2024.

Advisory Services Network reported no remaining BioVie position as of Q1 2024 after selling out during the quarter.
Advisory Services Network sold 41 BioVie shares in Q1 2024, an estimated $5.12K.
Advisory Services Network first reported a position in BioVie in Q2 2021 and held it in 4 quarters.
Advisory Services Network's BioVie position peaked at $10.3K in Q4 2022.
49 funds tracked by Wall St. Rank held BioVie as of Q1 2024.

Based on Advisory Services Network's 13F filing for Q1 2024, filed 6 May 2024.